{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"15.060","rs_stock_flag":false,"fiscal_year_end":"2024年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"1,973,026,508","primaryexch":"香港交易所","ric":"3933.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":1.4639,"inline_upper_strike_price":"","sedol":"B1P70H9","am":"177.23","iv":"","ew_strike":"","as":"14.820","geographic_focus":null,"incorpin":"開曼群島","etp_baseCur":null,"ew_amt_os":"","bd":"14.810","registrar":"香港中央證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"2,000","update_time":"2025-09-28 00:06:03.0","lo52":"8.475","shares_issued_date":"2025年8月31日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"蔡海山","underlying_ric":"3933.HK","hi52":"17.980","issuer_name":"聯邦制藥國際控股有限公司","h_share_flag":false,"ew_sub_per_from":"","div_yield":"4.12","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"14.530","mkt_cap":"29.24","f_aum_hkd":null,"ew_sub_per_to":"","ls":"14.820","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"-0.020","aum":"","issued_shares_class_B":null,"vo":"11.96","secondary_listing_flag":false,"listing_date":"2007年6月15日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"聯邦制藥國際控股有限公司","nm_s":"聯邦制藥","sym":"3933","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.010","strike_price":"","summary":"聯邦制藥國際控股有限公司是一家投資控股公司，主要從事銷售中間體產品、原料藥及製劑產品業務。該公司通過三個業務部門運營業務。中間體部從事銷售中間體產品業務。原料藥部從事銷售原料藥業務。製劑產品部從事銷售抗生素製劑產品、非抗生素製劑產品及空心膠囊業務。該公司通過其子公司還從事製造及銷售有機化肥業務。","op":"14.760","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"藥品","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"香港<br/>新界<br/>元朗工業村<br/>福宏街6號","pc":"-0.13","days_to_expiry":null,"underlying_code":null,"pe":"9.55","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"14.840","isin":"KYG8813K1085","moneyness":""}},"qid":"1759074093844"}
